Cite
HARVARD Citation
Zeidan, A. et al. (2021). TIM-3 pathway dysregulation and targeting in cancer. Expert review of anticancer therapy. 21 (5), pp. 523-534. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zeidan, A. et al. (2021). TIM-3 pathway dysregulation and targeting in cancer. Expert review of anticancer therapy. 21 (5), pp. 523-534. [Online].